During the past decade, Mzansi Ethical Research Centre conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 9 clinical trials were completed, i.e. on average, 90% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mzansi Ethical Research Centre" #1 sponsor was "Pfizer" with 2 trials, followed by "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored, "Wits Health Consortium (Pty) Ltd" with 2 trials sponsored, "Biota Scientific Management Pty Ltd" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mzansi Ethical Research Centre" #1 collaborator was "Bio Analytical Research Corporation" with 2 trials as a collaborator, "BioVac" with 2 trials as a collaborator, "Biocair" with 2 trials as a collaborator, "Clinical Laboratory Services" with 2 trials as a collaborator and "Dis-Chem Pharmacy" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Mzansi Ethical Research Centre" are "COVID-19" (3 trials), "COVID-19 Pneumonia" (1 trials), "Chronic Idiopathic Constipation" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "HIV Infections" (1 trials). Many other conditions were trialed in "Mzansi Ethical Research Centre" in a lesser frequency.

Most popular intervention types in "Mzansi Ethical Research Centre" are "Drug" (11 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "placebo" (4 trials), "PF-07321332" (2 trials), "Ritonavir" (2 trials) and "40 mg Laninamivir Octanoate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mzansi Ethical Research Centre" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Mzansi Ethical Research Centre". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Mzansi Ethical Research Centre, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Mzansi Ethical Research Centre, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".